Skip to content

CBD Task Force

CBD Task Force

Travis Moyer
Vice President of Business Development, Curaleaf

“Mr. Moyer is an experienced executive and attorney with a demonstrated history of successfully working in both entrepreneurial and institutional environments.  Having  worked in the United States cannabis industry since 2018, Mr. Moyer currently serves as Vice President of Business Development for Curaleaf where he manages various organic and acquisition-based growth strategies.  Prior to joining Curaleaf, Mr. Moyer served as the Vice President of Legal and Strategic Initiatives for Grassroots Cannabis where he led Grassroots’ legal and compliance teams as well as Grassroots’ organic growth strategies, growing Grassroots’ license footprint from 3 to 12 states in under 3 years.  Curaleaf finalized its purchase of Grassroots in July 2020 for roughly $900mm.

CBD Task Force

Barry J. Siegel
VP, Wedgewood Pharmacy

Barry J. Siegel is Vice President and General Counsel of Wedgewood Pharmacy, the largest provider of compounded drugs in the United States for animals.  He has been practicing corporate law for more than 30 years and previously served as General Counsel of Pernix Therapeutics Holdings, a specialty pharmaceutical company and as a shareholder of the law firm Buchanan Ingersoll & Rooney .  He graduated with a JD from New York University School of Law and a BA from University of Massachusetts.

CBD Task Force

Neil Willner

Neil is the Co-Chair of the Cannabis Group at Royer Cooper Cohen Braunfeld LLC.  Neil counsels hemp and marijuana companies operating on all tiers of the supply chain on the complex patchwork of state and federal regulation.  Relying on his deep knowledge of state-specific marijuana and hemp rules, Neil assists clients in strategically navigating the disharmonized industry.  Neil serves on the American Trade Association for Cannabis and Hemp’s CBD Task Force and Cannabis Beverage Council.

CBD Task Force

Jeremy Unruh
SVP, Public & Regulatory Affairs, PharmaCann Inc.

Jeremy Unruh serves as the PharmaCann senior vice president of regulatory and external affairs. He brings a fifteen-year track record as a government prosecutor and big firm lawyer to the nascent medical cannabis industry.

Beginning his career as a prosecutor, Jeremy was trained in trial advocacy by the United States Department of Justice at the National College of District Attorneys in Columbia, S.C. Before his eventual appointment as the first-chair prosecutor in the courtroom of the Chief Judge of the Criminal Division of the Circuit Court of Cook County, Illinois, Jeremy successfully investigated and tried drug cases, homicides, financial, and sexual abuse crimes.

Jeremy went into private practice for a national law firm that would reach the American Lawyer Top 100 during his tenure. Jeremy’s practice focused on commercial litigation, internal compliance investigations in the financial services and healthcare sectors, and product liability defense. He was the lead trial attorney on the national product liability trial team for a Fortune 100 industrial company for many years. He joined the firm’s Chicago office in 2006, where he helped grow the Chicago law firm from a handful of lawyers to an office of more than 100 lawyers when he left to join the cannabis industry in 2015.

Jeremy has a B.S. from Kansas State University. He earned a Juris Doctor from Washburn University School of Law where he was an inaugural recipient of the Environmental Law certificate. While serving as an assistant state’s attorney in Chicago, Jeremy attended DePaul University Kellstadt School of Business Management at night and earned his M.B.A. Jeremy lives in Winnetka, Illinois with his beautiful wife, three delightful children, and a half-witted dog.

CBD Task Force

Amy Gare
Co-Founder, Gare Group, LLC

Amy Gare is the Co-Founder and Chief Legal Officer of the Gare Group, LLC a cannabis consulting firm and a Partner at BPCM Cannabis, LLC, a cannabis branding and public relations firm. Amy previously held positions as the Assistant General Counsel and Deputy Ethics and Compliance Officer, at Capgemini North America and Head of Employment Law, The Royal Bank of Scotland North America as well as a Litigation Associate, Fried, Frank, Harris, Shriver and Jacobson, LLP.

CBD Task Force

Gary S. Kaminsky, Esq.

Senior Counsel, Royer Cooper Cohen Braunfeld, LLC

Mr. Kaminsky has over thirty-five years of experience in legal regulatory compliance, the past six in the cannabis industry. Mr. Kaminsky’s expertise is in developing and implementing regulatory enterprise risk management infrastructure for companies investing and operating in the cannabis industry as well as for asset management companies, broker-dealers and other financial institutions.

Mr. Kaminsky’s distinguished career began as a senior attorney with the Enforcement Division of the U.S. SEC in Washington. He was also co-founder, COO, CCO and General Counsel for two alternative investment fund companies and CCO and Counsel for Susquehanna Investment Group, a leading proprietary trading firm, preceded by a position as a securities and regulatory attorney with Dechert, LLP. Most recently, Mr. Kaminsky has advised US multi-state operators and other companies across the supply chain in the cannabis industry. Indeed, he is frequently turned to as an informational resource by state and federal regulators and law enforcement.

Mr. Kaminsky is frequent author and panelist for cannabis industry issues and currently Chief Regulatory Advisor for the American Trade Association for Cannabis and Hemp chairing its CBD Task Force and a founding member of its Cannabis Beverage and Capital Markets councils.

He received a BA from the University of North Carolina at Chapel Hill, and his Juris Doctor from the State University of New York at Buffalo.

CBD Task Force

Corey Burchman, MD
Chief Medical Officer, Acreage Holdings

He is a nationally recognized expert on clinical cannabinoid therapeutics, and has chaired multiple national and international conferences on the use of medical cannabis for therapeutic purposes. He is an anesthesiologist and pain management physician, having been in military, private and academic practice in a career spanning over 35 years.

His research and writings have been featured in scholarly peer-reviewed medical journals, popular press publications, the internet, podcasts, as well as multiple panels across the country.He testified before the FDA on cannabis.

As a 13 y Navy veteran, he actively lobbies on Capitol Hill for veteran’s safe access to cannabis.
A staunch proponent of education, he lectures about cannabis as medicine to doctors and patients throughout the world.

Among his goals as Medical Officer for Acreage, he brings the structure of evidence-based medicine to the cannabis world, with the emphasis on facts, not urban myth.
He guiding the cannabis industry in sowing the seeds of resources and energy towards patient safety, product development, and federal enlightenment.

He recently retired as Assistant Professor of Anesthesiology and Pain Medicine at the Geisel School of Medicine at Dartmouth, in Hanover, NH, where he directed the Section on Neuro-anesthesia, the Post Anesthesia Care Unit, and the Same Day Surgical Program.

He received his undergraduate education at Cornell University, his medical degree at the
George Washington School of Medicine and Health Sciences, and his residency and fellowship training at Harvard Medical School, the Massachusetts General Hospital and the Brigham and Women’s Hospital.

Dr. Burchman has been involved in humanitarian medical care for most of his adult life, primarily in South America, and most recently, Southeast Asia. Dr. Burchman has traveled extensively throughout lesser-developed countries. He co-founded The Global Children’s Art Programme, 16 years ago, a nonprofit bringing artists, art workshops, and materials to the children of developing nations.

He is both a serious poet and writer; the author of several collections, engaged in decades of creative writing and painting workshops from high school in Maryland, through college in upstate New York, and then as a medical resident at Harvard.

His hobbies are numerous, but include the alchemy of brewing beer, wilderness backpacking, blue-water sailing, skiing, and enjoying the outdoors in every season.

CBD Task Force

Sundie Seefried
CEO, Partner Colorado Credit Union & Safe Harbor Services, LLC

Sundie Seefried is presently the CEO of Partner Colorado Credit Union & Safe Harbor Services, LLC, located in Denver Colorado. She has served in the Credit Union industry since 1983 and as CEO since 2001. She holds a Bachelors in Business Management from the University of Maryland and an MBA in Finance from Regis University.

Instead of heading into retirement at the end of 2014, she designed a full scope Cannabis Banking Program known as the Safe Harbor program which has withstood the scrutiny of 15 Federal and State exams to date. The credit union now banks in excess of $250 million per month of cannabis related funds while creating the subsidiary Safe Harbor Services to aid other Financial Institutions implement the Safe Harbor program.

She regularly provides cannabis banking education to legislators, regulators, attorney’s generals, state officials and financial institutions and has established herself as an expert on the topic; having her program featured in the NY Times Magazine, January 2018. She is on a mission to normalize banking for the cannabis industry while assisting law enforcement and federal agencies be more effective at combating illicit activities and protecting the financial system.

To share her knowledge, she authored the book ‘Navigating Safe Harbor – Cannabis Banking in Uncertain Times’ in 2016, as well as contributing an entire chapter on cannabis banking in the newly released university textbook, The Politics of Marijuana: A New Paradigm, by Timothy McGettigan; both available on Amazon.

CBD Task Force

Seth A. Goldberg
Team Lead, Duane Morris Cannabis Industry Group

Seth A. Goldberg counsels clients in business and litigation, with a particular emphasis in highly regulated industries such as cannabis, pharmaceuticals and healthcare. He serves as a team lead for the Duane Morris Cannabis industry group, and has been recognized by various publications, including the prestigious Chambers and Partners, for his work in the cannabis space. Companies, directors, and individuals involved in commercial litigation, products liability and regulatory matters rely on Mr. Goldberg’s extensive experience with complex legal and business issues and his strategic decision-making to guide them toward optimal results.

As an active, seasoned trial lawyer, who regularly appears in federal and state courts, arbitral forums, and before federal and state regulatory agencies, including the SEC, FTC and state attorneys general, Mr. Goldberg has become a go-to lawyer in high-stakes cases and corporate investigations.

In addition, Mr. Goldberg’s unique experience in highly-regulated markets, combined with his entrepreneurial interests, has led to his involvement with the emerging cannabis (marijuana and hemp) industry. In this market he advises core and ancillary cannabis companies, including growers, processors, dispensaries, infused-product manufacturers, real estate developers, universities and university research centers, raw materials companies, and investors in a wide array of regulatory and business matters pertaining to their legal cannabis activities.

Mr. Goldberg spearheaded the establishment of the firm’s Cannabis Industry Group from 2015-2018, and has been appointed as a team lead for the group in 2019. In April 2020, Mr. Goldberg was recognized by Chambers and Partners as being in the “Top-Tier Nationwide” among lawyers who practice in the cannabis space, quoting a client as saying, “Seth is a great businessman – not only does he understand the law, but also the business realities of things, which makes him a great adviser from that perspective.” In November 2018, Mr. Goldberg was named one of the 30 powerful cannabis attorneys to know in the cannabis industry by MG Magazine, and in October 2018, Mr. Goldberg was recognized as a Trailblazer in Cannabis Law by the National Law Journal.